Advertisement

Topics

Conceptus Company Profile

20:27 EST 18th November 2017 | BioPortfolio

Conceptus, Inc. has developed Essure, an innovative medical procedure, designed to provide a non-incisional alternative to tubal ligation, the leading form of birth control worldwide. In the United States, Essure is currently an investigational device for non-incisional permanent birth control. The Essure procedure is based on a unique and proprietary micro-insert and catheter delivery system for minimally invasive transcervical tubal access. On April 19, 2002, Conceptus submitted an application to the Food and Drug Administration, seeking approval to market Essure in the United States. The availability of Essure in the U.S. is projected for 2003 and is expected to open up a market currently occupied by surgical tubal ligation and vasectomy, which combined account for more than 1 million sterilization procedures, annually.



The Common Stock of Conceptus has been traded on the Nasdaq National Market under the symbol CPTS since the effective date of the initial public offering on February 1, 1996.

Location

1021 Howard Ave.
San Carlos
CA
94070
United States of America

Contact

Phone: 650 802-7240
Fax: 650 610-8363
Email: bvoss@lhai.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Delivery of Morpholino Antisense Oligonucleotides to a Developing Ovine Conceptus via Luminal Injection into a Ligated Uterine Horn.

In vivo delivery of morpholino antisense oligonucleotides (MAO) directly into the uterine lumen of a peri-implantation period pregnant sheep is an effective technique for evaluation of gene products f...

Effect of lactation on conceptus-maternal interactions at the initiation of implantation in cattle: I. Effects on the conceptus transcriptome and amino acid composition of the uterine luminal fluid.

Approximately 65-75 days post-partum (dpp), the estrous cycles of non-lactating (dried off immediately post partum: n = 12) and lactating (n = 13) Holstein Friesian cows were synchronized and on D...

Vitamin D-metabolic enzymes and related molecules: Expression at the maternal-conceptus interface and the role of vitamin D in endometrial gene expression in pigs.

Vitamin D is a secosteroid hormone with many varied functions including regulation of blood calcium levels, cell proliferation, immunity, and reproduction in mammals. Vitamin D is activated by 25-hydr...

IFNT and fertility in ruminants.

Establishment of pregnancy in domestic ruminants includes pregnancy recognition signaling by the conceptus, implantation, and placentation. Despite the high fertilisation success rate in ruminants, a ...

Effect of metabolic status on conceptus-maternal interactions on Day 19 in dairy cattle: II. Effects on the endometrial transcriptome.

The aim of this study was to test the hypothesis that the metabolic stresses associated with lactation alter the ability of the endometrium to respond appropriately to the conceptus by examining endom...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages

For implantation of developing conceptus, placental cells need to invade mother's uterus to access maternal blood supply in a control manner. We have found a combination of maternal immun...

Comparison of Day 19 and Day 20 Artificial FET

In recent artificial frozen embryo transfers (FET) in which blastocysts vitrified on day 4 of culture and transferred on P+4, with blastocysts traditionally transferred on P+5, a high rate...

Companies [3 Associated Companies listed on BioPortfolio]

Conceptus Inc.

Conceptus, Inc. (NASDAQ: CPTS), is a leader in the design, development and marketing of innovative solutions in women's healthcare. The Mountain View, Calif.-based company manufac...

Conceptus, Inc.

Conceptus, Inc. is a leader in the design, development and marketing of innovative solutions in women's healthcare. The Company manufactures and markets Essure permanent birth con...

Conceptus

Conceptus, Inc. has developed Essure, an innovative medical procedure, designed to provide a non-incisional alternative to tubal ligation, the leading form of birth control worldwide. In the United St...

More Information about "Conceptus" on BioPortfolio

We have published hundreds of Conceptus news stories on BioPortfolio along with dozens of Conceptus Clinical Trials and PubMed Articles about Conceptus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Conceptus Companies in our database. You can also find out about relevant Conceptus Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record